Bariatric Surgery
Clinician's Perspective: • Eligibility Thresholds: In Asia, bariatric surgery is indicated for individuals with Class III obesity, defined as a Body Mass Index (BMI) of 35.0 or higher, or a BMI of 30.0 when accompanied by at least one obesity-related health condition. In patients with Type
Bariatric Surgery
Clinician's Perspective: • Dual Mechanism: The procedure functions through both Gastric Restriction (limiting the stomach's intake capacity) and Intestinal Malabsorption (reducing the surface area available for nutrient uptake). • Hormonal Modulation: Post-operative weight loss is significantly driven by increases in GLP-1 (glucagon-like peptide-1) and
Bariatric Surgery
Clinician's Perspective: • Mechanical Restriction: The procedure involves the surgical removal of approximately 80% of the stomach, leaving a narrow, tubular "sleeve" about the size of a banana. • Hormonal Modulation: Beyond physical size, the surgery significantly reduces the production of hunger-regulating hormones, which helps suppress appetite
Bariatric Surgery
Clinician's Perspective: • Superior Weight Maintenance: Roux-en-Y Gastric Bypass (RYGB) achieved a 65.9% excess body mass index loss compared to 56.1% for Sleeve Gastrectomy (SG) after 10 years. • Nearly 30% of patients who initially underwent a Sleeve Gastrectomy (32 out of 107 participants) required a
Bariatric Surgery
Clinician's Perspective: • Reduced Mortality: Metabolic-bariatric surgery was associated with a 49% reduction in all-cause mortality (the risk of death from any cause) compared to traditional non-surgical weight management. • Diabetes Advantage: Participants with Type 2 Diabetes saw the most significant gains, with a 59% reduction in
Bariatric Surgery
Clinician's Perspective: • Reduced Cancer Incidence: The study revealed that patients who underwent bariatric surgery had a 32% lower risk of developing obesity-associated cancers compared to those who did not have surgery. • Lower Cancer Mortality: Researchers observed a 48% reduction in cancer-related deaths among the surgical group,
Bariatric Surgery
Clinician's Perspective: • Clinical Efficacy: Metabolic Bariatric Surgery (weight loss surgery that alters the digestive system) resulted in an average total weight loss of 28.3%, nearly triple the 10.3% observed in the medication group. • Economic Impact: Over a 24-month period, surgical intervention saved an average of
Bariatric Surgery
Clinician's Perspective: • A synthesis of 13 randomized controlled trials involving 693 patients found that probiotics did not significantly improve weight loss outcomes compared to a placebo. • Minimal BMI impact: There was no clinically meaningful difference in postoperative Body Mass Index (BMI) between those taking probiotics and those who
Bariatric Surgery
Clinician's Perspective: • Consuming a minimum of 60g of protein daily or 1.2g per kg of ideal body weight is critical for Fat-Free Mass (muscle, bone, and organ tissue) preservation. • The Critical Six Months: The protective effect of high protein intake is most significant during the initial
Bariatric Surgery
Clinician's Perspective: • Significant Blood Sugar Reduction: The analysis of 3,855 participants revealed a consistent and significant drop in fasting blood glucose (the amount of sugar in the blood after an overnight fast). • Improved Post-Meal Response: Researchers identified a sharp decrease in postprandial glucose (the blood sugar